These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 3388655)

  • 21. Prostatic biology, histologic patterns and clinical consequences of transitional cell carcinoma.
    Lerner SP; Colen J; Shen S
    Curr Opin Urol; 2008 Sep; 18(5):508-12. PubMed ID: 18670276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coexisting adenocarcinoma of prostate in patients undergoing cystoprostatectomy for bladder cancer.
    Winfield HN; Reddy PK; Lange PH
    Urology; 1987 Aug; 30(2):100-1. PubMed ID: 3617289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transitional cell carcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer.
    Wood DP; Montie JE; Pontes JE; VanderBrug Medendorp S; Levin HS
    J Urol; 1989 Feb; 141(2):346-9. PubMed ID: 2913357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidental prostatic adenocarcinoma in patients undergoing radical cystoprostatectomy for bladder cancer.
    Abbas F; Hochberg D; Civantos F; Soloway M
    Eur Urol; 1996; 30(3):322-6. PubMed ID: 8931964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of patients with concurrent primary tumors of bladder and prostate.
    Selli C; Hinshaw W; Wolfe JA; Paulson DF
    Urology; 1983 Jun; 21(6):562-5. PubMed ID: 6868226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostatic occurrence of transitional cell carcinoma after intravesical chemotherapy.
    Lemmers MJ; Fuchs EF; Hatch TR; Lowe BA
    Urology; 1991 May; 37(5):423-7. PubMed ID: 2024389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unsuspected prostatic adenocarcinoma in patients who have undergone radical cystoprostatectomy for transitional cell carcinoma of the bladder.
    Pritchett TR; Moreno J; Warner NE; Lieskovsky G; Nichols PW; Cook BA; Skinner DG
    J Urol; 1988 Jun; 139(6):1214-6. PubMed ID: 3373591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The frequency of prostatic involvement in radical cystectomy specimens for transitional cell carcinoma of the bladder.
    Basiri A; Ozhand A; Karami H; Parham HA; Safarinejad MR
    J Pak Med Assoc; 2008 Sep; 58(9):479-81. PubMed ID: 18846793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Commentary on prostate and urothelial carcinoma in cystoprostatectomy specimens.
    Lotan Y
    J Urol; 2008 May; 179(5 Suppl):S33-4. PubMed ID: 18405746
    [No Abstract]   [Full Text] [Related]  

  • 30. Risk factors for mucosal prostatic urethral involvement in superficial transitional cell carcinoma of the bladder.
    Mungan MU; Canda AE; Tuzel E; Yorukoglu K; Kirkali Z
    Eur Urol; 2005 Nov; 48(5):760-3. PubMed ID: 16005563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urothelial carcinoma in the prostatic urethra and prostate: current controversies.
    Liedberg F; Chebil G; Månsson W
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):383-90. PubMed ID: 17338657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of prostatic involvement by urothelial carcinoma in radical cystoprostatectomy for bladder cancer.
    Mazzucchelli R; Barbisan F; Santinelli A; Scarpelli M; Galosi AB; Lopez-Beltran A; Cheng L; Kirkali Z; Montironi R
    Urology; 2009 Aug; 74(2):385-90. PubMed ID: 19501882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate.
    Frazier HA; Robertson JE; Dodge RK; Paulson DF
    Cancer; 1993 Jun; 71(12):3993-4001. PubMed ID: 8508365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BCG in management of transitional cell carcinoma invasive to prostate.
    Siami P; Chinn S; Clayton M; Ray V; Rubenstein M; Guinan P
    Urology; 1989 Dec; 34(6):381-2. PubMed ID: 2595884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coincident vesical transitional cell carcinoma and prostatic carcinoma. Clinical features and treatment.
    Androulakakis PA; Schneider HM; Jacobi GH; Hohenfellner R
    Br J Urol; 1986 Apr; 58(2):153-6. PubMed ID: 3697629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostatic involvement in bladder cancer. Prostate mapping in 20 cystoprostatectomy specimens.
    Mahadevia PS; Koss LG; Tar IJ
    Cancer; 1986 Nov; 58(9):2096-102. PubMed ID: 3530431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravesical bacillus Calmette-Guerin therapy for in situ transitional cell carcinoma involving the prostatic urethra.
    Bretton PR; Herr HW; Whitmore WF; Badalament RA; Kimmel M; Provet J; Oettgen HF; Melamed MR; Fair WR
    J Urol; 1989 Apr; 141(4):853-6. PubMed ID: 2926879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Effect of Complete Prostate Examination of Radical Cystoprostatectomy Specimen on the Final Stage of Urothelial Carcinoma of the Urinary Bladder and the Detection of Prostate Cancer.
    Yoo Y; Kim JM; Choi E; Park HS; Cho MS; Sung SH; Park S
    Arch Pathol Lab Med; 2023 Jun; 147(6):665-675. PubMed ID: 36094519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid testicular metastasis from bladder transitional urothelial carcinoma after radical cystoprostatectomy: A case report.
    Wu K; Fan J; Liang H; Yao Y; He D
    Medicine (Baltimore); 2019 Nov; 98(48):e18000. PubMed ID: 31770212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Editorial comment to characterization and risk stratification of prostate cancer in patients undergoing radical cystoprostatectomy.
    Szarvas T
    Int J Urol; 2013 Sep; 20(9):872. PubMed ID: 23379970
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.